Thebaine — Paramorphine (Opioid Precursor Alkaloid · Oxycodone · Buprenorphine · Naloxone)
| Compound | Thebaine (Paramorphine) |
| Chemical class | Alkaloid — Isoquinoline / Morphinan (6,7,8,14-Tetradehydro-4,5α-epoxy-3,6-dimethoxy morphinan) |
| CAS | 115-37-7 |
| Primary source | Papaver somniferum (opium, 0.2–1%) and Papaver bracteatum (Persian poppy, major alkaloid ~2–3%) |
| Key applications | Controlled pharmaceutical precursor; synthesis of oxycodone, hydrocodone, buprenorphine, naloxone, naltrexone; informational reference |
| Claim strength | High (pharmaceutical derivatives); Not applicable (thebaine itself) |
| Typical form | Pharmaceutical raw material; Schedule II controlled substance precursor; not a clinical drug itself |
| Buy from Herbuno | Browse HerbIQ Compound Index → |
Name origin: From Thebes (ancient Egyptian city; Thebae) — a historical centre of opium production, or possibly the Egyptian word for the opium poppy. Thebaine is a morphinan alkaloid structurally distinct from morphine and codeine — it has two methoxy groups (3,6-dimethoxy) and a different ring oxidation state, giving it a dienone structure rather than morphine’s phenol-alcohol. Unlike morphine and codeine, thebaine is convulsant rather than sedating at pharmacological doses — it produces CNS excitation and seizures, making it clinically useless as an analgesic. However, thebaine is the most pharmaceutically valuable alkaloid in opium — it is the precursor for an entire class of semi-synthetic opioids. Pharmaceutical importance: Thebaine (or the related alkaloid oripavine from P. bracteatum) is the starting material for: oxycodone (OxyContin), hydrocodone (Vicodin), hydromorphone (Dilaudid), oxymorphone, buprenorphine (Suboxone — opioid addiction treatment), naloxone (Narcan — opioid overdose reversal), and naltrexone (Vivitrol — opioid addiction treatment). Without thebaine, modern opioid pharmacotherapy as practised today would not exist. Regulatory status: Schedule II controlled substance in the US and equivalent in most markets. Produced under international narcotics control for pharmaceutical use only.
Thebaine — Pharmaceutical Chemistry Context
Semi-synthetic opioid synthesis from thebaine: The structural transformation from thebaine to pharmacologically useful agents involves: (1) oxycodone (thebaine + oxidation steps → 14-hydroxycodeinone → oxycodone); (2) buprenorphine (thebaine + Diels-Alder cycloaddition + further elaboration → buprenorphine with high MOR affinity and partial agonism); (3) naloxone (thebaine → noroxymorphone → naloxone by N-allylation — converting opioid agonism to competitive antagonism). The ability to convert the convulsant thebaine into potent analgesics, partial agonists, and antagonists demonstrates the remarkable structure-activity relationship malleability of the morphinan scaffold. Pharmaceutical chemistry reference.
Papaver bracteatum as thebaine source: Papaver bracteatum (Persian poppy or Iranian poppy) accumulates thebaine as its primary alkaloid (~2–3% of dry weight) with minimal morphine or codeine. Cultivation of P. bracteatum was developed as an alternative to P. somniferum for pharmaceutical thebaine supply — since P. bracteatum naturally produces the precursor without the diversion-risk alkaloids (morphine, codeine). Major P. bracteatum cultivation occurs in Tasmania (Australia), Spain, and Turkey under International Narcotics Control Board oversight. Agricultural and regulatory reference.
Naloxone — the life-saving derivative: Naloxone (Narcan) is a competitive opioid antagonist synthesised from thebaine. It has no agonist activity at any opioid receptor and competitively displaces opioids including fentanyl from MOR within 1–3 minutes of IV administration (longer for nasal/IM formulations). Naloxone is the standard treatment for opioid overdose and is now available without prescription in many US states and other markets as an emergency reversal agent. Every death prevented by naloxone traces back through chemistry to thebaine’s role as the pharmaceutical precursor. Life-saving pharmaceutical derivative.
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Frequently Asked Questions — Thebaine
Why is thebaine itself convulsant while morphine is sedating?
The structural difference that makes thebaine excitatory is its 6,7-double bond and 6-methoxy group, creating a dienone system that interacts with opioid receptors differently from morphine. Thebaine has higher affinity for the κ-opioid receptor (which mediates psychotomimetic and dysphoric effects) relative to μ-opioid receptor (which mediates analgesia and sedation). It also has partial antagonist character at MOR. The net effect is CNS excitation and convulsions rather than morphine’s sedation and analgesia. Chemical modification of thebaine removes or reverses these properties — producing analgesics and antagonists with the desired profile.
How is buprenorphine synthesised from thebaine?
The synthesis of buprenorphine from thebaine (developed by John Lewis at Reckitt & Colman in the 1960s–70s) is an elegant example of medicinal chemistry. Thebaine undergoes a Diels-Alder cycloaddition with methyl vinyl ketone to form the oripavine series intermediate, which is further elaborated through a series of functional group transformations including N-demethylation, N-cyclopropylmethylation (giving the unique buprenorphine N-substituent responsible for the partial agonist profile), and addition of the cyclopropylcarbinyl group at C7. The result is buprenorphine — a partial MOR agonist with extraordinarily high receptor affinity and slow dissociation that forms the pharmacological basis for addiction treatment.
What is the difference between Papaver somniferum and Papaver bracteatum for pharmaceutical production?
P. somniferum produces the full alkaloid complex (morphine + codeine + thebaine + papaverine + noscapine). P. bracteatum produces predominantly thebaine with minimal morphine/codeine — making it preferred for pharmaceutical thebaine supply without diversion-risk byproducts. However, P. bracteatum is a larger, more vigorous plant that requires different agronomic conditions and is less established as a licit crop in some regions. Tasmania has developed P. bracteatum cultivation as part of its pharmaceutical poppy industry.
Is there a botanical source of naloxone?
No — naloxone is entirely a semi-synthetic product requiring thebaine (or oripavine) as the chemical starting material. There is no plant that produces naloxone naturally. The competitive opioid antagonist pharmacophore (N-allyl substituted morphinan) does not occur in nature and was only accessible through the synthetic chemistry programme that transformed thebaine into the opioid antagonist class. This makes the pharmaceutical supply chain for naloxone entirely dependent on regulated cultivation of Papaver species.
Related compounds: Morphine, Codeine, Oripavine, Papaverine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery